← Leaderboards
Johannes Franciscus Van Agthoven
Massachusetts General Hospital
$797,460
Attributed
$797,460
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $160.7K · FY2015–19$200K$150K$100K$50K$0
'15
'16
'17
'18
'19
Funding mix
By agency
NIH$797,460 · 1
By mechanism
K01$797,460 · 1
Top collaborators
No co-investigators on record.
Most similar at Massachusetts General Hospital
Same institution · by research overlap
- Jochen Reiser$12,583,911
- M. Amin Arnaout$31,171,564
- Joseph Vincent Bonventre$46,605,730
- Hua A Lu$4,958,338
- Shannon K Bromley$5,700,330
Others in their field
Top investigators on “Fibronectins”
- Martin A. Schwartz · Yale University$11,822,401
- Timothy A Springer · Boston Children'S Hospital$11,405,849
- Richard F Loeser · Rush University Medical Center$9,001,150
- Sophie Astrof · Rutgers Biomedical And Health Sciences$8,825,404
- Jean E Schwarzbauer · Princeton University$8,747,637
- Donald B Arnold · University Of Southern California$7,985,852
Research focus
FibronectinsAdhesion ReceptorAdultExtracellular MatrixAffinityAgonistAnimal ModelBaseActinsAcuteCell AdhesionCell BehaviorCell MembraneCell MotilityCellsChronicCilengitideClinical TrialsComplexAffectCytoskeletonDepositionDesignImmune
Grant awards (5)
Novel Features of Integrin Antagonism Applied to Renal Dysfunction$159,192
K01 · FY2019 · DK · contact PI
Novel Features of Integrin Antagonism Applied to Renal Dysfunction$159,192
K01 · FY2018 · DK · contact PI
Novel Features of Integrin Antagonism Applied to Renal Dysfunction$159,192
K01 · FY2017 · DK · contact PI
Novel Features of Integrin Antagonism Applied to Renal Dysfunction$159,192
K01 · FY2016 · DK · contact PI
Novel Features of Integrin Antagonism Applied to Renal Dysfunction$160,692
K01 · FY2015 · DK · contact PI